Medical Device News Magazine

Independent Testing Of SANDD Pro™ for IEC And UL Certification Successfully Completed

Reports RedHawk Holdings

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

RedHawk Holdings Corp. has announced they have successfully completed the independent laboratory testing of its newly designed SANDD Pro™ needle incineration device. Testing was performed by Intertek PLC (“Intertek”) to independently confirm the SANDD Pro™ meets the safety requirements of both International Electrotechnical Commission 61010-1 and Underwriter Laboratories 61010-1 for the United States, Canada, and Europe; Certification Bodies Scheme for the United States, Canada, and Europe; and, Electrical Testing Laboratories Listing for the United States and Canada.

Intertek is a leading total quality assurance provider to industries worldwide with more than 46,000 employees in 1,000 locations in over 100 countries based in the UK. Intertek testing ensures products meet quality, health, environmental, safety, and social accountability standards for virtually any market around the world. Intertek holds extensive worldwide accreditations and recognitions.

“The successful independent lab testing of our newly designed SANDD Pro™ needle incineration unit was the final step before commencing production,” commented G. Darcy Klug, RedHawk’s Chairman, and Interim Chief Executive Officer. “We can now begin the production process and we expect to launch sales and leasing of theSANDD Pro™ needle incineration device, coupled with certain bio-hazard waste disposal services, during the summer of 2020.”

The SANDD Pro™ is capable of incinerating hypodermic needles 18-gauge and higher, up to 8 inches in length. The SANDD Pro™ technology also features a separate portable, rechargeable, lithium-ion battery-operated unit (the “SANDD Pro™ – Portable”) capable of incinerating as many as 300 needles, ranging in gauges as thick as 21 gauge and lengths up to 8″ on a single charge. RedHawk believes the SANDD Pro™ – Portable will be ideal for field use by first responders, home health care nurses, veterinarians, and home use injectors. The SANDD Pro™ is both FDA approved and OSHA compliant.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”